FIELD: chemistry.
SUBSTANCE: invention relates to 5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1λ6,2,5-thiadiazolidine-1,1,3-trione.
EFFECT: obtaining 5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1λ6,2,5-thiadiazolidine-1,1,3-trione, having inhibitory activity with respect to protein tyrosine phosphatase of non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase of non-receptor type 1 (PTPN1).
3 cl, 6 tbl, 232 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROTEIN-TYROSINPHOSPHATASE INHIBITORS AND METHODS OF THEIR USE | 2019 |
|
RU2799446C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
| METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES | 2002 |
|
RU2308451C2 |
| AMINOPYRIDINE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS | 2012 |
|
RU2612217C2 |
| COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND PROPHYLAXIS OF ENDOMETRITIS, INTERMEDIATE COMPOUND | 1996 |
|
RU2130454C1 |
| SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
| ARYL- OR HETEROARYLAMIDES OF TETRAHYDRONAPHTHALENE-, CHROMAN-, THIOCHROMAN- AND 1,2,3,4-TETRAHYDROQUINOLINE CARBOXYLIC ACIDS SHOWING RETINOID-LIKE BIOLOGICAL ACTIVITY | 1996 |
|
RU2163906C2 |
| TRICYCLIC TETRAHYDROISOQUINOLINE DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2021 |
|
RU2830109C1 |
| SUBSTITUTED PYRAZOLOPYRIMIDINES, METHOD FOR PREPARING AND USING THEM AS DRUG | 2007 |
|
RU2450004C2 |
